उत्पाद वर्णन
Empagliflozin 12.5 mg + Metformin 500 mg IR
Indication: Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. Combines SGLT2 inhibitor (Empagliflozin) and biguanide (Metformin) for dual action on glucose regulation. Not for type 1 diabetes or diabetic ketoacidosis.